Lions Aravind Institute of Community Ophthalmology, Aravind Eye Care System, Madurai, India.
Aravind Eye Care System, Madurai, India.
JAMA Ophthalmol. 2019 Jul 1;137(7):786-792. doi: 10.1001/jamaophthalmol.2019.1070.
Studies in high-income countries provide limited evidence from randomized clinical trials on the benefits of teleretinal screening to identify diabetic retinopathy (DR).
To evaluate the effectiveness of teleretinal-screening hospital referral (TR) compared with universal hospital referral (UR) in people with diabetes.
DESIGN, SETTING, AND PARTICIPANTS: A cluster randomized clinical trial of 8 diabetes clinics within 10 km from Aravind Eye Hospital (AEH), Madurai, India, was conducted. Participants included 801 patients older than 50 years. The study was conducted from May 21, 2014, to February 7, 2015; data analysis was performed from March 12 to June 16, 2015.
In the TR cohort, nonmydriatic, 3-field, 45° retinal images were remotely graded by a retinal specialist and patients with DR, probable DR, or ungradable images were referred to AEH for a retinal examination. In the UR cohort, all patients were referred for a retinal examination at AEH.
Hospital-diagnosed DR.
Of the 801 participants, 401 were women (50.1%) (mean [SD] age, 60.0 [7.3] years); mean diabetes duration was 8.6 (6.6) years. In the TR cohort, 96 of 398 patients (24.1%) who underwent teleretinal imaging were referred with probable DR (53 [13.3%]) or nongradable images (43 [10.8%]). Hospital attendance at AEH was proportionately higher with TR (54 of 96 referred [56.3%]) compared with UR (150 of 400 referred [37.5%]). The intention-to-treat analysis based on all patients eligible for referral in each arm showed that proportionately more patients with TR (36 of 96 [37.5]%) were diagnosed with DR compared with UR (50 of 400 [12.5%]) (unadjusted risk ratio [RR], 3.00; 95% CI, 2.01-4.48). These results were little changed by inclusion of covariates (RR, 2.72; 95% CI, 1.90-3.91). The RR was lower in the per-protocol analysis based on all patients who adhered to referral (covariate-adjusted RR, 1.75; 95% CI, 1.12-2.74). Diagnoses of DR were predominantly mild or moderate nonproliferative DR (36 in TR and 43 in UR). In the UR arm, there were 4 cases of severe nonproliferative DR and 2 cases of proliferative DR. Age (RR, 0.98; 95% CI, 0.95-0.99), female sex (RR, 0.79; 95% CI, 0.64-0.98), and hypertension diagnosis (RR, 0.81; 95% CI, 0.68-0.95) were factors associated with lower attendance. Those with higher secondary educational level or more were twice as likely to attend (RR, 2.00; 95% CI, 1.32-3.03).
The proportionate yield of DR cases was higher in the TR arm, confirming the potential benefit, at least in the setting of eye hospitals in India, of a targeted referral approach using teleretinal screening to identify patients with DR.
ClinicalTrials.gov identifier: NCT02085681.
重要性:高收入国家的研究提供了有限的证据,表明远程视网膜筛查对识别糖尿病视网膜病变(DR)有益,但仅限于随机临床试验。
目的:评估与普遍医院转诊(UR)相比,远程视网膜筛查转诊(TR)在糖尿病患者中的效果。
设计、地点和参与者:这是一项在印度马杜赖 Aravind 眼科医院(AEH)附近 10 公里范围内的 10 个糖尿病诊所进行的集群随机临床试验。参与者包括 801 名年龄大于 50 岁的患者。研究于 2014 年 5 月 21 日至 2015 年 2 月 7 日进行,数据分析于 2015 年 3 月 12 日至 6 月 16 日进行。
干预措施:在 TR 队列中,使用非散瞳、3 视野、45°视网膜图像由视网膜专家远程分级,将患有 DR、可能 DR 或无法分级图像的患者转诊至 AEH 进行视网膜检查。在 UR 队列中,所有患者均被转诊至 AEH 进行视网膜检查。
主要结果和测量指标:医院诊断的 DR。
结果:在 801 名参与者中,401 名是女性(50.1%)(平均[标准差]年龄,60.0[7.3]岁);平均糖尿病病程为 8.6(6.6)年。在 TR 队列中,398 名接受远程视网膜成像的患者中,有 96 名(24.1%)被转诊为可能 DR(53 名[13.3%])或无法分级图像(43 名[10.8%])。与 UR 组相比(54 名[56.3%]),TR 组在 AEH 的就诊率更高(96 名转诊患者中的 150 名[37.5%])。基于每个手臂中所有符合转诊条件的患者进行意向治疗分析显示,与 UR 组(400 名转诊患者中的 50 名[12.5%])相比,TR 组(96 名转诊患者中的 36 名[37.5%])诊断为 DR 的患者比例更高(未调整风险比[RR],3.00;95%置信区间[CI],2.01-4.48)。包括协变量后,结果变化不大(RR,2.72;95%CI,1.90-3.91)。基于所有遵守转诊的患者的符合方案分析,RR 较低(协变量调整 RR,1.75;95%CI,1.12-2.74)。DR 的诊断主要为轻度或中度非增生性 DR(TR 组 36 例,UR 组 43 例)。UR 组有 4 例严重非增生性 DR 和 2 例增生性 DR。年龄(RR,0.98;95%CI,0.95-0.99)、女性(RR,0.79;95%CI,0.64-0.98)和高血压诊断(RR,0.81;95%CI,0.68-0.95)是与就诊率较低相关的因素。那些具有较高的中学后教育水平或更高的患者,其就诊的可能性是前者的两倍(RR,2.00;95%CI,1.32-3.03)。
结论和相关性:TR 组的 DR 病例比例更高,这证实了在印度眼科医院的环境中,使用远程视网膜筛查对识别 DR 患者进行有针对性转诊的潜在益处。
试验注册:ClinicalTrials.gov 标识符:NCT02085681。